First Trust Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$537M Sell
4,465,569
-162,791
-4% -$18.8M 0.38% 48
2025
Q4
$487M Sell
4,628,360
-383,251
-8% -$36M 0.35% 60
2025
Q3
$421M Sell
5,011,611
-38,130
-0.8% -$3.14M 0.31% 70
2025
Q2
$400M Buy
5,049,741
+2,211,568
+78% +$176M 0.32% 64
2025
Q1
$255M Buy
2,838,173
+1,930,936
+213% +$180M 0.23% 102
2024
Q4
$90.3M Buy
907,237
+254,691
+39% +$26.3M 0.08% 299
2024
Q3
$74.1M Buy
652,546
+62,892
+11% +$7.47M 0.07% 330
2024
Q2
$73M Buy
589,654
+7,239
+1% +$932K 0.07% 288
2024
Q1
$76.8M Sell
582,415
-208,922
-26% -$25.8M 0.08% 294
2023
Q4
$86.3M Sell
791,337
-1,736,922
-69% -$180M 0.09% 264
2023
Q3
$260M Sell
2,528,259
-93,504
-4% -$10.1M 0.31% 64
2023
Q2
$303M Sell
2,621,763
-259,125
-9% -$29.4M 0.34% 48
2023
Q1
$306M Sell
2,880,888
-36,903
-1% -$3.98M 0.35% 43
2022
Q4
$324M Sell
2,917,791
-111,114
-4% -$11.4M 0.39% 38
2022
Q3
$261M Sell
3,028,905
-274,280
-8% -$24.5M 0.34% 46
2022
Q2
$301M Buy
3,303,185
+1,007,703
+44% +$89.3M 0.37% 40
2022
Q1
$188M Sell
2,295,482
-1,952,926
-46% -$154M 0.19% 153
2021
Q4
$326M Sell
4,248,408
-157,298
-4% -$12.5M 0.32% 57
2021
Q3
$331M Sell
4,405,706
-37,664
-0.8% -$2.86M 0.36% 43
2021
Q2
$346M Buy
4,443,370
+1,484,598
+50% +$110M 0.37% 39
2021
Q1
$218M Buy
2,958,772
+155,101
+6% +$11.4M 0.26% 83
2020
Q4
$219M Buy
2,803,671
+362,463
+15% +$27.7M 0.29% 66
2020
Q3
$193M Buy
2,441,208
+183,988
+8% +$14.4M 0.31% 67
2020
Q2
$167M Buy
2,257,220
+419,330
+23% +$31.6M 0.29% 68
2020
Q1
$135M Buy
1,837,890
+215,498
+13% +$16.9M 0.31% 52
2019
Q4
$141M Buy
1,622,392
+132,340
+9% +$10.9M 0.24% 78
2019
Q3
$120M Buy
1,490,052
+34,757
+2% +$2.79M 0.23% 79
2019
Q2
$116M Sell
1,455,295
-243,435
-14% -$18.6M 0.22% 94
2019
Q1
$135M Buy
1,698,730
+471,356
+38% +$35.3M 0.27% 66
2018
Q4
$89.5M Buy
1,227,374
+95,983
+8% +$6.78M 0.21% 90
2018
Q3
$76.6M Sell
1,131,391
-100,341
-8% -$6.39M 0.14% 159
2018
Q2
$71.3M Buy
1,231,732
+742,456
+152% +$41.9M 0.15% 135
2018
Q1
$25.4M Sell
489,276
-76,292
-13% -$4.12M 0.06% 433
2017
Q4
$30.4M Buy
565,568
+152,299
+37% +$8.44M 0.07% 358
2017
Q3
$25.3M Buy
413,269
+58,991
+17% +$3.58M 0.07% 383
2017
Q2
$21.7M Sell
354,278
-1,561,702
-82% -$95.1M 0.06% 454
2017
Q1
$116M Buy
1,915,980
+22,459
+1% +$1.36M 0.32% 35
2016
Q4
$106M Buy
1,893,521
+112,139
+6% +$6.56M 0.32% 34
2016
Q3
$106M Sell
1,781,382
-130,284
-7% -$7.62M 0.32% 43
2016
Q2
$105M Buy
1,911,666
+770,879
+68% +$41M 0.33% 44
2016
Q1
$57.6M Sell
1,140,787
-754,285
-40% -$36.9M 0.19% 110
2015
Q4
$95.5M Sell
1,895,072
-137,067
-7% -$6.91M 0.25% 82
2015
Q3
$95.8M Buy
2,032,139
+137,659
+7% +$7.31M 0.28% 75
2015
Q2
$103M Buy
1,894,480
+1,769,824
+1,420% +$99.3M 0.27% 82
2015
Q1
$6.84M Sell
124,656
-214,115
-63% -$12.1M 0.02% 915
2014
Q4
$18.4M Buy
338,771
+244,110
+258% +$13.6M 0.06% 431
2014
Q3
$5.35M Sell
94,661
-22,057
-19% -$1.24M 0.02% 991
2014
Q2
$6.44M Sell
116,718
-1,282,255
-92% -$70M 0.03% 861
2014
Q1
$75.8M Sell
1,398,973
-70,570
-5% -$3.65M 0.33% 36
2013
Q4
$70.2M Sell
1,469,543
-77,441
-5% -$3.54M 0.34% 30
2013
Q3
$70.3M Buy
1,546,984
+84,635
+6% +$3.86M 0.38% 28
2013
Q2
$64.8M Buy
+1,462,349
New +$65.3M 0.42% 16

Other funds holding MRK

First Trust Advisors's MRK Position: Q1 2026 in Review

First Trust Advisors reduced its Merck (MRK) stake by 3.5% in Q1 2026, selling an estimated $18.8M and leaving 4,465,569 shares worth $537M. The position accounts for 0.38% of the portfolio, ranked #48.

First Trust Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • First Trust Advisors held 4,465,569 shares of Merck worth $537M as of Q1 2026.
  • First Trust Advisors sold 162,791 Merck shares in Q1 2026, an estimated $18.8M.
  • Merck made up 0.38% of First Trust Advisors's portfolio in Q1 2026, its #48 holding.
  • First Trust Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.